Corticosteroid in Dengue Hemorrhagic Fever as Preventive Treatment of Severe Outcome: A Case Report

Nyoman Angga Santosa, Diah Pradnya Paramita, Made Wirama Diyana

Abstract: Dengue is known as the most common vector-borne viral infection between humans by Aedes genusmosquito. Dengue has a broad spectrum of disease, ranging from asymptomatic infection to a severe systemic plasma leakage syndrome. Pathogenesis of severe dengue stillpoorly understood, one factor that is thought to cause the dreaded shock syndrome is antibody-dependent enhancement. Despite of fluid replacement therapy as the main treatment, corticosteroids usage in order to suppress immune-mediated mechanisms in DHF also expected to prevent severe outcome. Since this is still controversial, further research is still very much needed.

Keywords: dengue hemorrhagic fever, dengue shock, corticosteroids, preventive treatment

How to Cite?: Nyoman Angga Santosa, Diah Pradnya Paramita, Made Wirama Diyana, "Corticosteroid in Dengue Hemorrhagic Fever as Preventive Treatment of Severe Outcome: A Case Report", Volume 11 Issue 2, February 2022, International Journal of Science and Research (IJSR), Pages: 1242-1245, https://www.ijsr.net/getabstract.php?paperid=SR22227092343, DOI: https://dx.doi.org/10.21275/SR22227092343